pill bottles The Food and Drug Administration (FDA) has approved several changes to the prescribing information for Plavix (clopidogrel bisulfate tablets; Bristol-Myers Squibb and Sanofi). The Food ...
CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack Positive opinion based on clinical data ...
Of the 128 patients who completed the study, 100 patients were eligible to be included in the platelet function analysis. After a 10-14 day run-in phase with open label clopidogrel 75 mg once daily ...
If you’re considering treatment options for managing certain kinds of heart conditions, you may want to learn more about Plavix (clopidogrel). It’s a prescription drug used to reduce the risk of heart ...
Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...
Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...
For the second time in the past six months, a cardiology mainstay drug has lost patent protection and gone generic. Today the FDA announced that it had approved several generic versions of clopidogrel ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
Pharmacogenomic Testing Shows Promise in Guiding Clopidogrel Antiplatelet Therapy in Poor Responders
NEW ORLEANS, LA—The debate over the use of pharmacogenomic- or pharmacodynamic-tailored antiplatelet therapy continues to be a subject of interest at ACC.11, the American College of Cardiology’s 60 th ...
Patients with high-risk features undergoing elective PCI and treated with the more-potent antiplatelet agent ticagrelor (Brilinta; AstraZeneca) instead of clopidogrel fared no better with respect to ...
Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
BRIDGEWATER and PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Sanofi-aventis and Bristol-Myers Squibb Company announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results